SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India - Quaterly Results

20 Oct 2022 Evaluate
The Sales for the quarter ended September 2022 of Rs. 9635.77 millions rose by 36.93% from Rs. 7036.94 millions.The company almost doubled its revenue to Rs. 1089.29 millions  from Rs. 460.96 millions in the quarter ended September 2022.The company reported a good operating profit of 1894.14 millions compared to 976.97 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 9635.77 7036.94 36.93 18849.34 14358.10 31.28 32384.37 31349.82 3.30
Other Income 37.51 42.83 -12.42 82.99 116.39 -28.70 175.10 137.23 27.60
PBIDT 1894.14 976.97 93.88 3906.23 2550.88 53.13 6621.59 8750.96 -24.33
Interest 83.61 40.12 108.40 128.00 93.96 36.23 163.52 237.74 -31.22
PBDT 1810.53 936.85 93.26 3778.23 2456.92 53.78 6458.07 8513.22 -24.14
Depreciation 348.68 318.56 9.46 694.67 633.52 9.65 1261.61 1184.51 6.51
PBT 1461.85 618.29 136.43 3083.56 1823.40 69.11 5196.46 7328.71 -29.09
TAX 372.56 157.33 136.80 746.59 463.99 60.91 1331.31 1800.87 -26.07
Deferred Tax -18.53 -2.72 581.25 -39.08 -8.03 386.67 -3.76 -169.74 -97.78
PAT 1089.29 460.96 136.31 2336.97 1359.41 71.91 3865.15 5527.84 -30.08
Equity 248.29 247.68 0.25 248.29 247.68 0.25 248.01 247.68 0.13
PBIDTM(%) 19.66 13.88 41.59 20.72 17.77 16.65 20.45 27.91 -26.75

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×